The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Biomarkers in Heart Failure: Focus on B-type Natriuretic Peptide

심부전 관련 Biomarkers: BNP를 중심으로

  • Yoo, Byung-Su (Division of Cardiology, Department Internal Medicine, Yonsei University Wonju College of Medicine)
  • 유병수 (연세대학교 원주의과대학 심장내과)
  • Published : 2012.06.01
⟨ Previous Next ⟩

Abstract

Assays for B-type natriuretic peptide (BNP) or N-terminal pro-brain BNP (NTproBNP) BNP are useful diagnostic method for evaluation of patients with dyspnea. And, natriuretic peptide levels have important prognostic value in heart failure. Therefore, measurements of BNP or NT-proBNP, taken together with conventional clinical assessment, may assist in the decision of treatment process. The following brief review summarizes available information concerning clinical significance of BNP or NT-proBNP.

Keywords

References

  1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446. https://doi.org/10.1056/NEJM197112232852601
  2. YooBS, Kim WJ, Kim JY, et al. The clinical experience of B-type natriuretic peptide blood concentrations for diagnosis in congestive heart failure-The single hospital experience based on the large clinical database. Korean Circ J 2004; 34:684-690. https://doi.org/10.4070/kcj.2004.34.7.684
  3. Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 2004;10:1-30.
  4. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167. https://doi.org/10.1056/NEJMoa020233
  5. Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation. 2003;108:2964-2966. https://doi.org/10.1161/01.CIR.0000106903.98196.B6
  6. Bayes-Genis A, Santalo-Bel M, Zapico-Muniz E, et al. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 2004;15:301-308.
  7. Gopal DJ, Iqbal MN, Maisel A. Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med 2011;123:102-113. https://doi.org/10.3810/pgm.2011.11.2500

Cited by

  1. Establishing Reference Intervals for Soluble ST2 Assay in a Korean Population vol.7, pp.4, 2012, https://doi.org/10.3343/lmo.2017.7.4.176
  2. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure vol.17, pp.None, 2012, https://doi.org/10.1186/s12872-017-0632-0
  3. 경기도 일개 종합병원에서 Pro-Brain Natriuretic Peptide와 통상적 혈액검사 인자간의 상관성 조사 vol.52, pp.3, 2012, https://doi.org/10.15324/kjcls.2020.52.3.172